1-4 of 4
Linda A Pestano, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Trial of Cobomarsen, an Inhibitor of Mir-155, in Cutaneous T Cell Lymphoma

Christiane Querfeld, MD, PhD, Francine M. Foss, MD, Youn H. Kim, MD, Lauren Pinter-Brown, MD, Basem M. William, MRCP, MD, Pierluigi Porcu, MD, Theresa Pacheco, MD, Bradley M. Haverkos, MD, MPH, MS, Jennifer DeSimone, MD, Joan Guitart, MD, Ahmad S Halwani, MD, Herbert A. Eradat, MD, MS, Auris Huen, MD, Kristin Schroeder, PhD, Linda A. Pestano, PhD, Paul J. Williams, Jr., Ioanna Cheronis, Gilad S. Gordon, MD, MBA, Diana Escolar, MD, FAAN, Paul Rubin, MD, William S. Marshall, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2903.
https://doi.org/10.1182/blood-2018-99-119861
Published: 2018
Journal Articles

Phase 1 Study of the Safety and Efficacy of MRG-106, a Synthetic Inhibitor of microRNA-155, in CTCL Patients

Christiane Querfeld, MD PhD, Francine M Foss, MD, Lauren C. Pinter-Brown, MD, Pierluigi Porcu, MD, Basem M. William, MRCP,MD, Theresa Pacheco, MD, Bradley M. Haverkos, MD MPH, MS, Youn H. Kim, MD, Joan Guitart, MD, Ahmad S. Halwani, MD, Jennifer DeSimone, MD, Anita G Seto, PhD, Linda A Pestano, PhD, Aimee L Jackson, PhD, Paul J Williams, Jr., Brent A Dickinson, Judy Ruckman, PhD, Gilad Gordon, MDMBA, Paul Rubin, MD, Bill S Marshall, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 820.
https://doi.org/10.1182/blood.V130.Suppl_1.820.820
Published: 2017
Journal Articles

Preliminary Results of a Phase 1 Trial Evaluating MRG-106, a Synthetic microRNA Antagonist (LNA antimiR) of microRNA-155, in Patients with CTCL

Christiane Querfeld, MD PhD, Theresa Pacheco, MD, Francine M. Foss, MD, Ahmad S. Halwani, MD, Pierluigi Porcu, MD, Anita G Seto, PhD, Judy Ruckman, PhD, Michele L Landry, Aimee L Jackson, PhD, Linda A Pestano, PhD, Brent A Dickinson, Mark Sanseverino, David M Rodman, MD, Gilad Gordon, MD MBA, William Marshall, PhD
Journal: Blood
Blood (2016) 128 (22): 1829.
https://doi.org/10.1182/blood.V128.22.1829.1829
Published: 2016
Journal Articles

Preclinical Results Supporting Therapeutic Development of Mrg-106, an Oligonucleotide Inhibitor of Mir-155, in CTCL

Anita G Seto, PhD, Xuan T Beatty, BS, Linda A Pestano, PhD, Brent A Dickinson, BA, Marshelle S Warren, MD, David M Rodman, MD, Aimee L Jackson, PhD
Journal: Blood
Blood (2015) 126 (23): 2758.
https://doi.org/10.1182/blood.V126.23.2758.2758
Published: 2015